BIMI International Medical Inc.
BIMI International Medical Inc. (BIMI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bimi · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BIMI International Medical Inc. (BIMI) measures how much investors pay for each dollar of the company's trailing earnings. BIMI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$8.40.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2003 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%0.6x
MedianQ3 · 75%252.8x
Max
At N/A, BIMI's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BIMI International Medical Inc.You BIMI | $0M | N/A | — | -$8.40 |
 Adynxx, Inc. ADYX | $0M | N/A | — | -$10.26 |
 BG Medicine, Inc. BGMD | $0M | N/A | — | -$0.55 |
 ContraFect Corporation CFRXQ | $0M | N/A | — | -$124.97 |
 DMK Pharmaceuticals Corporation DMKPQ | $0M | N/A | — | -$12.37 |
 eFFECTOR Therapeutics, Inc. EFTR | $0M | N/A | — | -$16.37 |
 FusionPharm, Inc. FSPM | $0M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-8.40 | — | |
2021-12-31 FY2021 | — | $-65.24 | — | |
2020-12-31 FY2020 | — | $-24.80 | — | |
2019-12-31 FY2019 | — | $-27.17 | — | |
2018-12-31 FY2018 | — | $-112.25 | — | |
2017-12-31 FY2017 | — | $-11.10 | — | |
2016-12-31 FY2016 | — | $-14.00 | — | |
2015-12-31 FY2015 | — | $-7.73 | — | |
2014-12-31 FY2014 | — | $-5.50 | — | |
2013-12-31 FY2013 | — | $-1.64 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BIMI International Medical Inc. (BIMI) measures how much investors pay for each dollar of the company's trailing earnings. BIMI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$8.40.
Frequently asked questions
BIMI pe ratio · 6 questionsBIMI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$8.40. Data sourced from Financial Modeling Prep via BIMI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BIMI International Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08